The main objective of the clinical study is to evaluate the performance of the CT LUCIA 601
PY for the monocular uncorrected distance visual acuity and compare it to the reference
monofocal IOL Acrysof IQ SN60WF.
Device: Implantation of CT LUCIA IOL
Device: Implantation of Acrysof IQ SN60WF IOL
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02903927
Ages eligible for Study
50 Years to 90 Years
Genders eligible for Study
Accepts Healthy Volunteers
IOL implanted in the capsular bag;
The IOL model (CT LUCIA 601PY or Acrysof IQ SN60WF) has been implanted;
No intraoperative complications; no damaged capsular bag, no intraocular hemorrhage; no can opener rhexis.
• Patients unable to meet the limitations of the protocol or likely of non-cooperation during the trial;
Patients whose freedom is impaired by administrative or legal order;
Current participation in another drug or device investigation;
Allergy to heparin
Ocular disorders, other than cataract, that could potentially cause future acuity loss to a level of 0.20 logMAR (best-corrected) or worse the operated eye
Any anterior segment pathology that could significantly affect outcomes (e.g. chronic uveitis, iritis, corneal dystrophy, etc.)
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.